English
Specials
    Upgrade
    MoneycontrolBe a PRO
    Moneycontrol PRO
    you are here: HomeNewsBusinessMoneycontrol Research

    Sun Pharma: Time for investors to exit?

    Even though further traction in specialty products and domestic business is expected, we believe this may not be enough to offset the running expense on brands/products and field force.

    Anubhav Sahu
    May 31, 2022 / 12:33 PM IST
    Sun Pharma: Time for investors to exit?

    PRO Only Highlights
    -      Quarterly performance largely backed by improved realisations
    -      Medium-term triggers China plus and protectionist measures for tyre industry
    -      Valuations not inexpensive; but improved medium-term outlook

    Sun Pharma (CMP: Rs 888; Market Cap: Rs 213,133 crore) has posted a lacklustre set of numbers for Q4 with a sequential drop in both sales and margins. While cost headwinds have recently emerged, the company is focused on investing in specialty and domestic businesses — the twin drivers of growth. The management has guided to an increase in R&D spend and an expansion of the field force in the coming quarters. (image) Specialty products – weighed down by drop in...

    • PRO Panorama

      Moneycontrol Pro Panorama | India firmly on growth path

      Jun 1, 2023 / 02:18 PM IST

      In today’s edition of Panorama: India Inc and GDP, economy puts on running shows, JK Paper’s growth script, helicopter parent...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender: Things fall apart

      Apr 22, 2023 / 11:16 AM IST

      The mainstream is coming around to the view that geopolitics will result in a fragmented global economy and we will not go back to...

      Read Now

    To read the full story, Subscribe to Moneycontrol PRO

    Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

    View Plans

    Already a member? Sign in

    Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

    50% OFF

    What Do You Get

    • Ad free experience

      Experience a non-intrusive navigation and faster response in the ad free mode

    • Sharpest Opinions

      Access to 230+ exclusive stories per month from our editorial and Experts

    • +

      Have a Global edge with access to content from world renowned experts and journalist

    • Actionable Insights

      Access to 40+ weekly investment ideas including 4 daily technical calls

    • Virtual Events

      Exclusive access to live webinars from market experts on trading and investment strategies

    • Newsletters

      Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

    View Offers

    Get upto 50% discount on limited period offers